Dmedglobal
732 employees on LinkedIn · 2 known investors
Caidya is a global full-service clinical research organization (CRO) that supports biopharmaceutical companies with clinical trial design, execution, and patient recruitment across more than 40 countries. It provides patient-centric clinical trial solutions and high-quality data delivery across core therapeutic areas.
Investors · 2
Frequently asked questions
- What does Dmedglobal do?
- Caidya is a global full-service clinical research organization (CRO) that supports biopharmaceutical companies with clinical trial design, execution, and patient recruitment across more than 40 countries. It provides patient-centric clinical trial solutions and high-quality data delivery across core therapeutic areas.
- Who are Dmedglobal's investors?
- Dmedglobal's investors include Qiming Venture Partners, Quan Capital.